Medcomp Sciences LLC

Medcomp Sciences LLC was paid $12.95M by Medicaid between Jan 2018 and Jun 2023, across 139 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 34% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Louisiana

Rank by total paid#5 of 66

Median peer was paid$253K

This provider vs. median51×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	259,299	$4.64M
2019	200,347	$4.17M
2020	69,525	$1.90M
2021	17,265	$493K
2022	28,573	$1.40M
2023	4,424	$338K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	34%	38,969	24,411	$4.34M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	11%	36,576	23,155	$1.38M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	9.9%	15,656	9,047	$1.29M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	7.3%	28,535	12,581	$949K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	3.8%	16,427	11,461	$493K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.4%	5,417	2,221	$312K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.4%	3,193	1,575	$187K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.2%	2,755	1,533	$158K
80372		1.2%	15,654	12,291	$150K
80368		1.1%	14,847	11,635	$143K
80346		1.0%	15,218	11,858	$132K
80337		1.0%	11,110	8,489	$131K

127 more codes

80361		<1%	15,885	$123K
80367		<1%	11,191	$123K
80364		<1%	15,208	$120K
80365		<1%	15,865	$120K
80348		<1%	15,472	$120K
80354		<1%	15,249	$117K
80358		<1%	15,417	$116K
80360		<1%	14,961	$112K
80324		<1%	15,830	$112K
80359		<1%	15,810	$108K
80353		<1%	15,868	$107K
80349		<1%	13,652	$106K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	9,921	$106K
80356		<1%	12,787	$103K
80321		<1%	14,630	$95K
80338		<1%	7,651	$92K
83992		<1%	12,685	$89K
80344		<1%	7,552	$86K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	624	$83K
80334		<1%	6,563	$83K
87900		<1%	968	$75K
80350		<1%	8,143	$71K
80373		<1%	8,712	$62K
80370		<1%	6,997	$59K
87640		<1%	3,743	$57K
80366		<1%	7,679	$57K
80332		<1%	7,506	$57K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,463	$47K
87653		<1%	2,876	$45K
80355		<1%	7,844	$44K
80323		<1%	5,168	$43K
80357		<1%	5,108	$38K
80345		<1%	7,527	$37K
87529		<1%	1,907	$34K
87481		<1%	2,043	$34K
80375		<1%	4,625	$33K
87799		<1%	3,954	$32K
80371		<1%	5,593	$31K
87500		<1%	1,384	$27K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	898	$19K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	895	$19K
87482		<1%	1,015	$18K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	984	$17K
87641		<1%	1,223	$15K
87186		<1%	325	$14K
87511		<1%	922	$14K
87486		<1%	592	$12K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,919	$10K
87581		<1%	628	$7K
83970		<1%	248	$7K
87563		<1%	322	$7K
87541		<1%	573	$7K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	810	$6K
87496		<1%	810	$6K
87532		<1%	789	$5K
80369		<1%	1,155	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	266	$5K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	393	$4K
80299		<1%	409	$4K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	109	$4K
82670		<1%	193	$3K
80050	General health panel	<1%	221	$3K
87631		<1%	65	$3K
87652		<1%	412	$3K
84403		<1%	192	$3K
82627		<1%	193	$3K
82533		<1%	249	$3K
84270		<1%	192	$3K
84144		<1%	192	$3K
84432		<1%	231	$3K
84146		<1%	192	$2K
83001		<1%	192	$2K
83002		<1%	192	$2K
86376		<1%	232	$2K
82668		<1%	185	$2K
82607		<1%	261	$2K
80061	Lipid panel	<1%	395	$2K
82746		<1%	217	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	17	$2K
83525		<1%	234	$2K
84238		<1%	80	$2K
83010		<1%	195	$2K
84481		<1%	234	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	381	$1K
86141		<1%	146	$1K
82728		<1%	232	$1K
84439		<1%	249	$1K
84466		<1%	235	$1K
84702		<1%	233	$1K
83735		<1%	247	$1K
82150		<1%	247	$1K
82977		<1%	277	$1K
83615		<1%	236	$955.59
80053	Comprehensive metabolic panel	<1%	265	$901.18
84443	Thyroid stimulating hormone (TSH)	<1%	175	$878.17
84550		<1%	248	$767.79
86431		<1%	180	$649.75
82248		<1%	247	$647.70
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	248	$621.32
84402		<1%	33	$608.16
84154		<1%	48	$603.60
83540		<1%	231	$544.68
80363		<1%	122	$536.58
84153		<1%	52	$512.40
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	36	$443.61
86762		<1%	31	$342.00
87340		<1%	37	$257.77
81003		<1%	263	$249.08
80342		<1%	113	$247.83
86780		<1%	32	$239.30
86140		<1%	250	$214.73
86850		<1%	32	$99.75
86592		<1%	37	$95.00
80159		<1%	792	$90.60
85660		<1%	23	$70.00
84480		<1%	207	$67.04
85027		<1%	28	$65.00
86900		<1%	32	$55.86
86901		<1%	32	$55.29
85007		<1%	29	$52.00
85652		<1%	45	$31.90
84436		<1%	202	$21.05
81001		<1%	25	$18.75
83550		<1%	136	$8.71
82950		0%	30	$0.00
83721		0%	186	$0.00
82172		0%	34	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBEASLEY, WILLIAM (AUTHORIZED OFFICIAL)